** Brokerage Morgan Stanley starts coverage on hospital operator Tenet Healthcare THC.N with "overweight" rating and $165 PT
** New PT represents 26.2% upside to the stock's last close
** Brokerage says significant changes in business model and balance sheet not yet reflected in THC's stock price
** Brokerage believes co is well-positioned to benefit from the shift towards outpatient care as outpatient visits have grown ~30% from 2000 to 2022, driven by technological enhancements, reimbursement changes and consumer preferences
** Notes THC's key growth areas include orthopedics, urology, cardiology, GI and cancer
** Including session moves, THC stock up 4.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))